Unknown PHASE1 INTERVENTIONAL 6-arm NCT03127046

Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers (DW6008)

A Randomized, Open-label, Single Dose, 3-way Crossover Study to Evaluate the Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers

Sponsor: Dong Wha Pharmaceutical Co. Ltd.

Conditions Healthy

Interventions Aceclofenac Aceclofenac and Esomeprazole Esomeprazole

Updated 7 times since 2017 Last updated: Apr 23, 2017 Started: Mar 31, 2017 Primary completion: Apr 16, 2017 Completion: Apr 23, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03127046, this PHASE1 trial focuses on Healthy and remains ongoing. Sponsored by Dong Wha Pharmaceutical Co. Ltd., it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE1
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
May 2019 — Jan 2021 [monthly]

Unknown Status PHASE1

Status: Enrolling By Invitation → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — May 2019 [monthly]

Enrolling By Invitation PHASE1
May 2017 — Jun 2018 [monthly]

Enrolling By Invitation PHASE1

First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dong Wha Pharmaceutical Co. Ltd.

Data source: Dong Wha Pharmaceutical Co. Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jeonju, South Korea